M. Girós

1.5k total citations
40 papers, 749 citations indexed

About

M. Girós is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, M. Girós has authored 40 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 13 papers in Physiology. Recurrent topics in M. Girós's work include Peroxisome Proliferator-Activated Receptors (21 papers), Metabolism and Genetic Disorders (13 papers) and Adipose Tissue and Metabolism (8 papers). M. Girós is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (21 papers), Metabolism and Genetic Disorders (13 papers) and Adipose Tissue and Metabolism (8 papers). M. Girós collaborates with scholars based in Spain, Belgium and United Kingdom. M. Girós's co-authors include Teresa Pàmpols, Montserrat Ruíz, Carme Camps, Aurora Pujol, Isidró Ferrer, Jean‐Louis Mandel, Noëlle Callizot, C. Hindelang, Stéphane Fourcade and Ronald J. A. Wanders and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Annals of the New York Academy of Sciences.

In The Last Decade

M. Girós

36 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Girós Spain 16 556 267 215 85 81 40 749
Brunhilde Molzer Austria 14 696 1.3× 381 1.4× 272 1.3× 67 0.8× 40 0.5× 37 825
Brigham B. Hyde United States 6 635 1.1× 194 0.7× 142 0.7× 52 0.6× 26 0.3× 8 883
Émilie Obre France 9 525 0.9× 94 0.4× 64 0.3× 70 0.8× 55 0.7× 11 772
Marie‐France Robert Canada 13 1.2k 2.1× 224 0.8× 107 0.5× 155 1.8× 106 1.3× 13 1.4k
Janine Reunert Germany 20 507 0.9× 342 1.3× 90 0.4× 18 0.2× 71 0.9× 45 880
Tomoyuki Yamasaki Japan 15 564 1.0× 145 0.5× 90 0.4× 92 1.1× 238 2.9× 36 899
Ann Snowden United States 9 468 0.8× 135 0.5× 70 0.3× 16 0.2× 47 0.6× 11 598
Neelanjan Vishnu Sweden 15 487 0.9× 158 0.6× 61 0.3× 30 0.4× 205 2.5× 17 747
Saara Forsström Finland 4 536 1.0× 191 0.7× 163 0.8× 64 0.8× 14 0.2× 5 720
Emilie Schrepfer Italy 7 456 0.8× 105 0.4× 70 0.3× 49 0.6× 30 0.4× 7 633

Countries citing papers authored by M. Girós

Since Specialization
Citations

This map shows the geographic impact of M. Girós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Girós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Girós more than expected).

Fields of papers citing papers by M. Girós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Girós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Girós. The network helps show where M. Girós may publish in the future.

Co-authorship network of co-authors of M. Girós

This figure shows the co-authorship network connecting the top 25 collaborators of M. Girós. A scholar is included among the top collaborators of M. Girós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Girós. M. Girós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Launay, Nathalie, Carmen Aguado, Stéphane Fourcade, et al.. (2014). Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy. Acta Neuropathologica. 129(3). 399–415. 38 indexed citations
2.
Cañueto, Javier, M. Girós, & Rogelio González‐Sarmiento. (2013). The role of the abnormalities in the distal pathway of cholesterol biosynthesis in the Conradi–Hünermann–Happle syndrome. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(3). 336–344. 15 indexed citations
3.
Sobrido, M.J., et al.. (2011). Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis. SHILAP Revista de lepidopterología. 26(7). 397–404. 15 indexed citations
4.
Sobrido, M.J., et al.. (2011). Utilidad de los niveles de colestanol en el diagnóstico y seguimiento de los pacientes con xantomatosis cerebrotendinosa. Neurología. 26(7). 397–404. 11 indexed citations
5.
Coria, F., Miguel A García-Viejo, Juan Duarte, et al.. (2009). Diagnosis of X-adrenoleucodystrophy phenotypic variants. Acta Neurologica Scandinavica. 87(6). 499–502.
6.
Fourcade, Stéphane, Montserrat Ruíz, Carme Camps, et al.. (2008). A key role for the peroxisomalABCD2transporter in fatty acid homeostasis. American Journal of Physiology-Endocrinology and Metabolism. 296(1). E211–E221. 86 indexed citations
7.
Ribacoba, Renée, et al.. (2008). Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy. International Archives of Medicine. 1(1). 5–5. 11 indexed citations
9.
Pujol, Aurora, Isidró Ferrer, Carme Camps, et al.. (2004). Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Human Molecular Genetics. 13(23). 2997–3006. 158 indexed citations
10.
Roels, Frank, Jean‐Marie Saudubray, M. Girós, et al.. (2003). Peroxisome Mosaics. Advances in experimental medicine and biology. 544. 97–106. 7 indexed citations
11.
Moser, Hugo W., Gerald V. Raymond, Wolfgang Köehler, et al.. (2003). Evaluation of the Preventive Effect of Glyceryl Trioleate-Trierucate (“Lorenzo’s Oil”) Therapy in X-Linked Adrenoleukodystrophy: Results of Two Concurrent Trials. Advances in experimental medicine and biology. 544. 369–387. 42 indexed citations
12.
Roels, Frank, Marianne Depreter, M. Girós, et al.. (2002). Differential organ involvement in peroxisomal disorders. Journal of Inherited Metabolic Disease. 25. 99–99.
13.
Pàmpols, Teresa, M. Pineda, M. Girós, et al.. (1999). Neuronopathic juvenile glucosylceramidosis due to sap -C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Acta Neuropathologica. 97(1). 91–97. 38 indexed citations
14.
Pineda, Mercédes, M. Girós, Frank Roels, et al.. (1999). Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism. Journal of Child Neurology. 14(7). 434–439. 15 indexed citations
15.
Roy, Susana Quijano, et al.. (1997). Síndrome de Smith-Lemli-Opitz. Anomalía en la síntesis del colesterol. Anales de Pediatría. 46(6). 617–620. 1 indexed citations
16.
Roels, Frank, Tom Tytgat, Sonja Beken, et al.. (1996). Peroxisome Mosaics in the Liver of Patients and the Regulation of Peroxisome Expression in Rat Hepatocyte Culturesa. Annals of the New York Academy of Sciences. 804(1). 502–515. 13 indexed citations
17.
Barceló, Anna, et al.. (1996). Identification of two new nonsense mutations Q311X and W326X in Exon 2 of the adrenoleukodystrophy (ALD) gene. Human Mutation. 8(3). 286–287. 4 indexed citations
18.
Girós, M., Frank Roels, J M Prats, et al.. (1996). Long Survival in a Case of Peroxisomal Biogenesis Disorder with Peroxisome Mosaicism in the Liver. Annals of the New York Academy of Sciences. 804(1). 747–749. 14 indexed citations
19.
Barceló, Anna, M. Girós, Claude‐Olivier Sarde, et al.. (1994). Identification of a new frameshift mutation (1801delAG) in the ALD gene. Human Molecular Genetics. 3(10). 1889–1890. 23 indexed citations
20.
Girós, M. & Luis Alvarez. (1991). Hepatic glycogenosis with defects in the glycogen breakdown pathway: Urinary oligosaccharide profile. Journal of Inherited Metabolic Disease. 14(3). 311–313. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026